HK Stock MarketDetailed Quotes

CANSINOBIO (06185)

Watchlist
  • 28.280
  • -0.500-1.74%
Trading May 7 13:36 CST
6.99BMarket Cap-5656.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CANSINOBIO (06185) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
疫苗相关产品销售1.01B95.45%
提供开发及制造服务31.44M2.97%
技术转让收入及半成品销售16.81M1.59%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
流脑疫苗产品967.75M91.35%
CDMO31.44M2.97%
COVID-19疫苗产品22.67M2.14%
肺炎球菌疫苗20.74M1.96%
技术转移及中间品16.81M1.59%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China1.01B95.49%
Overseas47.75M4.51%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.88%
Sample Name
Sample Code
 +2.60%
Sample Name
Sample Code
 +2.45%
4
SHANGHAI PECHEM
00338
+0.78%
5
SINOPEC CORP
00386
-1.06%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +68.99%
Sample Name
Sample Code
 +59.08%
Sample Name
Sample Code
 +46.25%
4
Emdoor Information
001314
+41.73%
5
Business-intelligence Of Oriental Nations Corporation
300166
+25.97%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -